Itamar Medical to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Itamar Medical Ltd. (NASDAQ: ITMR) announced participation in two upcoming investor conferences. Management will present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021, at 8:00 a.m. ET, and at the 41st Annual Cowen Health Care Conference on March 4, 2021, at 10:30 a.m. ET. Webcasts will be available on the company’s website. Itamar Medical focuses on non-invasive medical devices for diagnosing respiratory sleep disorders, offering a Total Sleep Solution to enhance patient care.

CAESAREA, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the company will participate in two upcoming investor conferences.

Itamar Medical’s management team is scheduled to present at the 10^th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 8:00 a.m. ET/5:00 a.m. PT. Interested parties may access a live and archived webcast of the presentation on the investor section of the Company’s website at: www.itamar-medical.com.

Itamar Medical’s management team is scheduled to present at the 41^st Annual Cowen Health Care Conference on Thursday, March 4, 2021 at 10:30 a.m. ET/7:30 a.m. PT. Interested parties may access a live and archived webcast of the presentation on the investor section of the Company’s website at: www.itamar-medical.com.

About Itamar Medical Ltd.
Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the U.S., Japan and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com.

Itamar Medical Investor Relations Contact (U.S.)
Leigh Salvo
Gilmartin Group
Phone: +1-415-937-5412
investors@itamar-medical.com

FAQ

What are the dates and times for Itamar Medical's upcoming presentations at investor conferences?

Itamar Medical will present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021, at 8:00 a.m. ET, and at the 41st Annual Cowen Health Care Conference on March 4, 2021, at 10:30 a.m. ET.

Where can I watch Itamar Medical's investor conference presentations?

You can access live and archived webcasts of Itamar Medical's presentations on the investor section of their website.

What is Itamar Medical's primary focus in the healthcare market?

Itamar Medical focuses on the development and commercialization of non-invasive medical devices for diagnosing respiratory sleep disorders.

What is the key product of Itamar Medical?

The key product of Itamar Medical is the WatchPAT, which is used for sleep apnea management.

In which markets is Itamar Medical's WatchPAT available?

The WatchPAT is available in major markets including the U.S., Japan, and Europe.